PSA Failure Predicts Death in Men With No, Minimal Comorbidity

This article originally appeared here.
Share this content:
PSA Failure Predicts Death in Men With No, Minimal Comorbidity
PSA Failure Predicts Death in Men With No, Minimal Comorbidity

THURSDAY, Sept. 8, 2016 (HealthDay News) -- Prostate-specific antigen (PSA) failure is associated with increased risk of all-cause mortality for men with intermediate- or high-risk prostate cancer with no or minimal comorbidity, according to a study published online Sept. 6 in the Journal of Clinical Oncology.

Nicholas J. Giacalone, M.D., from Brigham and Women's Hospital in Boston, and colleagues examined whether PSA failure is associated with the risk of all-cause mortality stratified by comorbidity score. Two hundred six men with localized intermediate- and high-risk prostate cancer were randomized to receive radiation therapy or radiation therapy and six months of androgen deprivation therapy.

After a median follow-up of 16.62 years, the researchers found that 76 percent of the men died, and 19 percent of those men died as a result of prostate cancer. Among men with no or minimal comorbidity, PSA failure was associated with an increased risk of all-cause mortality (adjusted hazard ratio, 1.59; 95 percent confidence interval, 1.03 to 2.46; P = 0.04); this was not the case for men with moderate or severe comorbidity (adjusted hazard ratio, 1.75; 95 percent confidence interval, 0.76 to 3.99; P = 0.19).

"Recommending treatment on the basis of reduced PSA failure observed from early results of randomized controlled trials is unlikely to prolong survival in men with moderate-to-severe comorbidity but may prolong survival in men with no or minimal comorbidity, providing evidence to support discussing the early results with these men," the authors write.

One author disclosed financial ties to the biopharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ultraviolet B Radiation Exposure Tied to Decreased Risk of Myopia

Ultraviolet B Radiation Exposure Tied to Decreased Risk ...

More exposure to sun's UVB rays between ages 14 and 29 linked to lower risk

Vitamin D in Pregnancy Might Help Prevent MS in Offspring

Vitamin D in Pregnancy Might Help Prevent MS ...

Infants born with low levels of vitamin D may be more likely to develop multiple sclerosis later in life

Dabigatran May Be Better Than Warfarin After Bleeding Episode

Dabigatran May Be Better Than Warfarin After Bleeding ...

Resuming any anticoagulant found safer than stopping the drugs in these cases

is free, fast, and customized just for you!

Already a member?

Sign In Now »